Effect of sulfasalazine on renal ischemiaReperfusion injury in rats

Renal Failure

Volumn 31, Issue 9, 2009, Pages 822-828

  Cámara Lemarroy, Carlos Rodrigo ^a   Guzmán De La Garza, Francisco Javier ^a   Alarcón Galván, Gabriela ^b   Cordero Pérez, Paula ^a   Fernndez Garza, Nancy Esthela ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Injury; Ischemia reperfusion; Rat; Renal; Sulfasalazine

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; PADGEM PROTEIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SHAM PROCEDURE; UREA NITROGEN BLOOD LEVEL;

EID: 71049167204     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903151427     Document Type: Article

References (43)

1. Böhmová R, Viklicki O. Renal ischemia-reperfusion injury: An inescapable event affecting kidney transplantation outcome. Folia Microbiol (Praha). 2001;46:267-276.
2. Toledo-Pereyra LH, Toledo AH, Walsh J, Lopez-Neblina F. Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transplant. 2004;2:174-177.
3. Thurman JM. Triggers of inflammation after renal ischemia/ reperfusion. Clin Immunol. 2007;123:7-13.
4. Nichols TC. NF-kappaB and reperfusion injury. Drug News Perspect. 2004;17:99-104.
5. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol. 2000;163:1328-1332.
6. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007;97:738-747.
7. Meldrum KK, Hile K, Meldrum DR, Crone JA, Gearhart JP, Burnett AL. Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol. 2002;168:248-252.
8. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: A histopathologic study. Ren Fail. 2009;31:70-74.
9. Tsoulfas G, Geller DA. NF-kappaB in transplantation: Friend or foe? Transpl Infect Dis. 2001;3:212-219.
10. Takano T, Brady HR. The endothelium in glomerular inflammation. Curr Opin Nephrol Hypertens. 1995;4:277-286.
11. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008;109:102-107.
12. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med. 2008;14:502-516.
13. Dragun D, Haller H. Diapedesis of leukocytes: Antisense oligonucleotides for rescue. Exp Nephrol. 1999;7:185-192.
14. Kurata H, Takaoka M, Kubo Y, et al. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur J Pharmacol. 2005;517:232-239.
15. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y. Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (Lond). 2002;103 (Suppl.) 48:68S-71S.
16. Chatterjee PK, di Villa Bianca RD, Sivarajah A, McDonald MC, Cuzzocrea S, Thiemermann C. Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol. 2003;482:271-280.
17. Cao CC, Ding XQ, Ou ZL, et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 2004;65:834-845.
18. Lutz J, Luong le A, Strobl M, et al. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med. 2008;86:1329-1339.
19. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998;101:1163-1174.
20. Feeley BT, Park AK, Hoyt EG, Robbins RC. Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. J Heart Lung Transplant. 1999;18:1088-1095.
21. Matsui N, Kasajima K, Hada M, et al. Inhibiton of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci. 2005;30:103-110.
22. Loverre A, Ditonno P, Crovace A, et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: Differential modulation by rapamycin. J Am Soc Nephrol. 2004;15:2675-2686.
23. Demirbilek S, Emre MH, Aydin EN, et al. Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction. Pediatr Nephrol. 2007;22:804-812.
24. Tugcu V, Ozbek E, Tasci AI, et al. Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int. 2006;98:680-686.
25. Chatterjee PK, Cuzzocrea S, Brown PA, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 2000;58:658-673. (Pubitemid 30620015)
26. Tugtepe H, Sener G, Biyikli NK, et al. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul Pept. 2007;140:101-108.
27. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997;51:1463-1468.
28. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol. 2000;279:F809-F818.
29. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J. 2000;14:48-54. (Pubitemid 30051522)
30. Pooley N, Ghosh L, Sharon P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig Dis Sci. 1995;40:219-225.
31. Veale DJ, Maple C, Kirk G, McLaren M, Belch JJ. Soluble cell adhesion molecules-P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol. 1998;27:296-299.
32. Zizzi HC, Zibari GB, Granger DN, et al. Quantification of P-selectin expression after renal ischemia and reperfusion. J Pediatr Surg. 1997;32:1010-1013.
33. Battistini B, Dussault P. The many aspects of endothelins in ischemia-reperfusion injury: Emergence of a key mediator. J Invest Surg. 1998;11:297-313.
34. Ajis A, Bagnall NM, Collis MG, Johns EJ. Effect of endothelin antagonists on the renal haemodynamic and tubular responses to ischaemia-reperfusion injury in anaesthetised rats. Exp Physiol. 2003;88:483-490.
35. Jerkic M, Miloradovic Z, Jovovic D, et al. Relative roles of endothelin-1 and angiotensin II in experimental postischaemic acute renal failure. Nephrol Dial Transplant. 2004;19:83-94.
36. Müller DN, Dechend R, Fiebeler A, Park JK, Haller H, Luft FC. Angiotensin-induced inflammation and novel approaches to treatment. Adv Nephrol Necker Hosp. 2001;31:89-103.
37. Takaoka M, Ohkita M, Matsumura Y. Pathophysiological role of proteasome-dependent proteolytic pathway in endothelin-1-related cardiovascular diseases. Curr Vasc Pharmacol. 2003;1:19-26.
38. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemiareperfusion. Am J Physiol. 1999;277:R922-R929.
39. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol. 1999;162:196-203.
40. Han SL, Yu LX, Ma JJ, et al. Effect of anti-tumor necrosis factor-alpha monoclonal antibody in alleviating renal ischemia-reperfusion injury. Di Yi Jun Yi Da Xue Xue Bao. 2003;23:332-334.
41. Kim YK, Yoo JH, Woo JS, Jung JS, Kim BS, Kim SY. Effect of pentoxifylline on ischemic acute renal failure in rabbits. Ren Fail. 2001;23:757-772.
42. Danis VA, Franic GM, Rathjen DA, Laurent RM, Brooks PM. Circulating cytokine levels in patients with rheumatoid arthritis: Results of a double blind trial with sulphasalazine. Ann Rheum Dis. 1992;51:946-950.
43. Bissonnette EY, Enciso JA, Befus AD. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells. J Immunol. 1996;156:218-223.